880 related articles for article (PubMed ID: 19527933)
1. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
2. Possible anticancer agents: QSAR analogs of glutamamide: synthesis and pharmacological activity of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides.
Samanta S; Alam SM; Panda P; Jha T
Eur J Med Chem; 2009 Jan; 44(1):70-82. PubMed ID: 18456372
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, pharmacological activity and comparative QSAR modeling of 1,5-N,N'-substituted-2-(substituted naphthalenesulphonyl) glutamamides as possible anticancer agents.
Halder AK; Adhikary N; Maity MK; Jha T
Eur J Med Chem; 2010 May; 45(5):1760-71. PubMed ID: 20133022
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.
Nie Z; Perretta C; Erickson P; Margosiak S; Lu J; Averill A; Almassy R; Chu S
Bioorg Med Chem Lett; 2008 Jan; 18(2):619-23. PubMed ID: 18055206
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells.
Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY
Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806
[TBL] [Abstract][Full Text] [Related]
8. 3,5-Diaryl-1H-pyrazole as a molecular scaffold for the synthesis of apoptosis-inducing agents.
Shaw AY; Liau HH; Lu PJ; Yang CN; Lee CH; Chen JY; Xu Z; Flynn G
Bioorg Med Chem; 2010 May; 18(9):3270-8. PubMed ID: 20381360
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities.
Abou El Ella DA; Ghorab MM; Noaman E; Heiba HI; Khalil AI
Bioorg Med Chem; 2008 Mar; 16(5):2391-402. PubMed ID: 18086527
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of novel 2-amino-4-(4-phenylpiperazino)- 1,3,5-triazine derivatives.
Pomarnacka E; Bednarski P; Grunert R; Reszka P
Acta Pol Pharm; 2004; 61(6):461-6. PubMed ID: 15794339
[TBL] [Abstract][Full Text] [Related]
12. A TOPological Sub-structural Molecular Design (TOPS-MODE)-QSAR approach for modeling the antiproliferative activity against murine leukemia tumor cell line (L1210).
Molina-Ruiz R; Saíz-Urra L; Rodríguez-Borges JE; Pérez-Castillo Y; González MP; García-Mera X; Cordeiro MN
Bioorg Med Chem; 2009 Jan; 17(2):537-47. PubMed ID: 19114309
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents.
Ishar MP; Singh G; Singh S; Sreenivasan KK; Singh G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1366-70. PubMed ID: 16332438
[TBL] [Abstract][Full Text] [Related]
14. Rapid and efficient synthesis of 4-substituted pyrazol-5-one under microwave irradiation in solvent-free conditions.
Zahran MA; El-Essawy FA; Yassin SM; Salem TA; Boshta NM
Arch Pharm (Weinheim); 2007 Nov; 340(11):591-8. PubMed ID: 17924363
[TBL] [Abstract][Full Text] [Related]
15. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.
Al-Obaid AM; Abdel-Hamide SG; El-Kashef HA; Abdel-Aziz AA; El-Azab AS; Al-Khamees HA; El-Subbagh HI
Eur J Med Chem; 2009 Jun; 44(6):2379-91. PubMed ID: 18950904
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
17. The structure-based design, synthesis, and biological evaluation of DNA-binding amide linked bisintercalating bisanthrapyrazole anticancer compounds.
Hasinoff BB; Zhang R; Wu X; Guziec LJ; Guziec FS; Marshall K; Yalowich JC
Bioorg Med Chem; 2009 Jul; 17(13):4575-82. PubMed ID: 19457675
[TBL] [Abstract][Full Text] [Related]
18. Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives.
Farag AM; Mayhoub AS; Barakat SE; Bayomi AH
Bioorg Med Chem; 2008 Jan; 16(2):881-9. PubMed ID: 17962022
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of coumarin heterocyclic derivatives with antioxidant activity and in vitro cytotoxic activity against tumour cells.
Manojkumar P; Ravi TK; Subbuchettiar G
Acta Pharm; 2009 Jun; 59(2):159-70. PubMed ID: 19564141
[TBL] [Abstract][Full Text] [Related]
20. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]